Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 302

1.

Firm Erythematous Nodules in a Hospitalized Infant.

Ginsberg DN, Cheng CE, Barrio VR.

Pediatr Dermatol. 2017 Sep;34(5):614-616. doi: 10.1111/pde.13245. No abstract available.

PMID:
28884920
2.

ASK1 (MAP3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity, molecularly defining a human dys-metabolic obese phenotype.

Haim Y, Blüher M, Konrad D, Goldstein N, Klöting N, Harman-Boehm I, Kirshtein B, Ginsberg D, Tarnovscki T, Gepner Y, Shai I, Rudich A.

Mol Metab. 2017 May 6;6(7):725-736. doi: 10.1016/j.molmet.2017.05.003. eCollection 2017 Jul.

3.

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis.

Drake MJ, Nitti VW, Ginsberg DA, Brucker BM, Hepp Z, McCool R, Glanville JM, Fleetwood K, James D, Chapple CR.

BJU Int. 2017 Jul 3. doi: 10.1111/bju.13945. [Epub ahead of print] Review.

PMID:
28670786
4.

Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline.

Kobashi KC, Albo ME, Dmochowski RR, Ginsberg DA, Goldman HB, Gomelsky A, Kraus SR, Sandhu JS, Shepler T, Treadwell JR, Vasavada S, Lemack GE.

J Urol. 2017 Oct;198(4):875-883. doi: 10.1016/j.juro.2017.06.061. Epub 2017 Jun 15.

PMID:
28625508
5.

Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder.

Ginsberg DA, Drake MJ, Kaufmann A, Radomski S, Gousse AE, Chermansky CJ, Magyar A, Nicandro JP, Nitti VW; 191622-096 Investigators.

J Urol. 2017 Oct;198(4):897-904. doi: 10.1016/j.juro.2017.05.068. Epub 2017 May 20.

PMID:
28536084
6.

The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells.

Brodie S, Lee HK, Jiang W, Cazacu S, Xiang C, Poisson LM, Datta I, Kalkanis S, Ginsberg D, Brodie C.

Oncotarget. 2017 May 9;8(19):31785-31801. doi: 10.18632/oncotarget.15991.

7.

A novel lncRNA, GASL1, inhibits cell proliferation and restricts E2F1 activity.

Gasri-Plotnitsky L, Ovadia A, Shamalov K, Nizri-Megnaji T, Meir S, Zurer I, Cohen CJ, Ginsberg D.

Oncotarget. 2017 Apr 4;8(14):23775-23786. doi: 10.18632/oncotarget.15864.

8.

Editorial Comment.

Ginsberg DA.

J Urol. 2017 Jul;198(1):210. doi: 10.1016/j.juro.2017.01.113. Epub 2017 Apr 7. No abstract available.

PMID:
28396059
9.

Urologic Management and Complications in Spinal Cord Injury Patients: A 40- to 50-year Follow-up Study.

Gao Y, Danforth T, Ginsberg DA.

Urology. 2017 Jun;104:52-58. doi: 10.1016/j.urology.2017.03.006. Epub 2017 Mar 16.

PMID:
28322903
10.

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.

Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P; EINSTEIN CHOICE Investigators.

N Engl J Med. 2017 Mar 30;376(13):1211-1222. doi: 10.1056/NEJMoa1700518. Epub 2017 Mar 18.

PMID:
28316279
11.

Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.

Gamell C, Gulati T, Levav-Cohen Y, Young RJ, Do H, Pilling P, Takano E, Watkins N, Fox SB, Russell P, Ginsberg D, Monahan BJ, Wright G, Dobrovic A, Haupt S, Solomon B, Haupt Y.

Sci Signal. 2017 Jan 10;10(461). pii: eaaf8223. doi: 10.1126/scisignal.aaf8223.

PMID:
28074012
12.

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial.

Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C; EMBARK Study Group.

J Urol. 2017 Feb;197(2S):S216-S223. doi: 10.1016/j.juro.2016.10.109. Epub 2016 Dec 22.

PMID:
28012773
13.

OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder: Pro.

Ginsberg DA.

J Urol. 2017 Jan;197(1):11-13. doi: 10.1016/j.juro.2016.10.033. Epub 2016 Oct 11. No abstract available.

PMID:
27742453
14.

Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications.

Rac G, Younger A, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, MacLachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner ES.

Neurourol Urodyn. 2017 Apr;36(4):1155-1160. doi: 10.1002/nau.23080. Epub 2016 Jul 26.

PMID:
27460448
15.

Debates in allergy medicine: Specific immunotherapy in children with atopic dermatitis, the "con" view.

Ginsberg DN, Eichenfield LF.

World Allergy Organ J. 2016 Apr 18;9:16. doi: 10.1186/s40413-016-0107-2. eCollection 2016.

16.

Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study.

Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, De Ridder D, Jenkins B, Magyar A, Chapple C; 191622-096 Investigators.

J Urol. 2016 Sep;196(3):791-800. doi: 10.1016/j.juro.2016.03.146. Epub 2016 Mar 30.

PMID:
27038769
17.

Outcomes of Autologous Fascia Pubovaginal Sling for Patients with Transvaginal Mesh Related Complications Requiring Mesh Removal.

McCoy O, Vaughan T, Nickles SW, Ashley M, MacLachlan LS, Ginsberg D, Rovner E.

J Urol. 2016 Aug;196(2):484-9. doi: 10.1016/j.juro.2016.02.2976. Epub 2016 Mar 17.

PMID:
26997314
18.

Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison.

Freemantle N, Ginsberg DA, McCool R, Fleetwood K, Arber M, Khalaf K, Loveman C, Ni Q, Glanville J.

BMJ Open. 2016 Feb 23;6(2):e009122. doi: 10.1136/bmjopen-2015-009122.

19.

Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications.

Younger A, Rac G, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, Maclachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner E.

Urology. 2016 May;91:46-51. doi: 10.1016/j.urology.2015.12.057. Epub 2016 Feb 1.

PMID:
26845051
20.

LncRNA Khps1 Regulates Expression of the Proto-oncogene SPHK1 via Triplex-Mediated Changes in Chromatin Structure.

Postepska-Igielska A, Giwojna A, Gasri-Plotnitsky L, Schmitt N, Dold A, Ginsberg D, Grummt I.

Mol Cell. 2015 Nov 19;60(4):626-36. doi: 10.1016/j.molcel.2015.10.001.

Supplemental Content

Loading ...
Support Center